drugs that can specifically promote healing. Now a research team led by Professor Dr. Kai Wollert, Head of Molecular and Translational Cardiology at the Department of Cardiology and Angiology at Hannover
pleased to now be able to start the study programme together with you," said Prof. Dr. Thomas Schulz, head of the MHH Institute of Virology and spokesperson of the RESIST Cluster of Excellence, at the opening
there are about 50 teams from six institutions. RESIST spokesperson is Professor Dr Thomas Schulz, head of the MHH Institute of Virology. RESIST is funded by the German Research Foundation (DFG) from 2019
that this new knowledge reaches those affected directly," says Professor Brigitte Schlegelberger, head of the FBREK Centre and the Institute of Human Genetics at the MHH. Professor Dr. Peter Hillemanns
training for almost two years now. As part of the new professorship, the pulmonologist, who also heads a working group at the German Centre for Lung Research (DZL) at the BREATH Hannover site, will focus
better adapt the treatment to the individual needs of the patients," explains Professor Dr. Kai Kahl, head of the MHH study centre. The ChangePDD project is funded by the German Research Foundation with two
therapy to inhibit cancer development In the earlier clinical trial, Professor Heuser, who also heads the Research Strategy and Translational Research department at the CCC Hannover, combined the active
therapy goals more effectively,” explains PhD student and project coordinator Saskia Hamers. The team headed by Professor Krüger wants to find out whether self-chosen measures can improve the well-being of
y used worldwide and can make pregnancy possible without a corpus luteum forming," emphasises the head of the Reproductive Medicine and Molecular Perinatology working group at the MHH Women's Hospital
bacterial infections. The spokesperson of the cluster of excellence is Professor Dr. Thomas Schulz, head of the MHH Institute of Virology. More information is available here: www.RESIST-cluster.de Further